Treatment News

HIV-Related Death Rate Drops by Half in Seven Years

PrEP Referrals for Highest-Risk Groups Need Major Boost

Latin American cashier scanning products at a grocery store wearing a facemask - quarantine lifestyle

What’s New in COVID-19 Research?

HIV-Related Death Rate Drops by Half in Seven Years

PrEP Referrals for Highest-Risk Groups Need Major Boost

What’s New in COVID-19 Research?

HIV Tied to Lower Prostate Cancer Risk

So concluded a pooled analysis of 27 studies mostly conducted in higher income nations.

Doctor-Patient Shared Decision-Making Can Help Guide PrEP Use Choices

At a recent conference, a leading infectious disease provider in New York City advocated this as a means of improving patient satisfaction.

Testing, Treating Hep C in Australian Gay and Bi Men With HIV Drives Down New Cases

Hepatitis C commonly spreads through condomless sex and injection drug use among men who have sex with men.

Third COVID-19 Vaccine May Be Up to 90% Effective

The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.

Viral Reservoir’s Production of HIV RNA Tied to Harmful Inflammation

The amount of virus hidden in reservoir cells was not tied to inflammation in a small study, but the cells’ production of new RNA was.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

POZ March 2019 cover U=U Undetectable = Untransmitable

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

COVID-19 Vaccine Is 95% Effective, Pfizer Says

The front-runner coronavirus vaccine appears to protect people from symptomatic disease.

HIV Treatment Doesn’t Eliminate Accelerated Cell Aging

People with untreated HIV in a recent study had signs of faster cell aging, which treatment reduced but did not eliminate.

3D model of SARS-CoV2 coronavirus (back) and its spike protein (front) that enables the virus to enter human cells.

Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine

The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.

State Policies Create Barriers to Hepatitis C Elimination

Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.

Treatment News

HIV-Related Death Rate Drops by Half in Seven Years

PrEP Referrals for Highest-Risk Groups Need Major Boost

What’s New in COVID-19 Research?

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Hot topics

#Cure

#Long-Term Survivors

#Prevention

#PrEP

Features

Newsfeed

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ